1. RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.
- Author
-
de Vasconcelos PC, Freitas TR, de Araújo Lopes LV, Peixoto LR, Xavier MP, Cançado Figueiredo AC, Dias KL, de Oliveira JG, de Oliveira Salles PG, Vago AR, de Paula Sabino A, and de Lima Rocha MG
- Subjects
- Humans, Female, Middle Aged, Adult, Immunohistochemistry methods, Biomarkers, Tumor metabolism, Shelterin Complex, Aged, Papillomavirus Infections virology, Papillomavirus Infections metabolism, Papillomavirus Infections pathology, Papillomavirus Infections diagnosis, Telomere-Binding Proteins metabolism, Uterine Cervical Neoplasms metabolism, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms diagnosis, Precancerous Conditions metabolism, Precancerous Conditions pathology
- Abstract
Aim: This study investigated RAP1 immunostaining variation in different cell types during CC progression. Methods: Paraffin-embedded cervical tissues from 101 patients were categorized into control, pre-neoplastic and neoplastic groups. RAP1 immunolocalization, HPV detection and genotyping were performed. A semiquantitative immunoreactive score was employed to compare labeling intensity, cellular localization, nuclear labeling, percentage and distribution of reactive cells. Results: 73% (72/99) of cervical specimens were HPV+. RAP1 was localized in the nucleus and cytoplasm of all samples. Cytoplasmic RAP1 immunoscore was higher than nuclear score in all CC groups. RAP1 intensity increased with lesion severity. SCC samples exhibited predominantly intense RAP1 immunostaining. Conclusion: RAP1 is an efficient biomarker for detecting invasive CC lesions but has limited utility in distinguishing SCC grades.
- Published
- 2024
- Full Text
- View/download PDF